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Abstract
Background: Estrogen therapy is widely used nowadays in women to treat many postmenopausal
symptoms but it may have some undesirable effects due to multiple organs affection. So, the aim of
this study was to determine the effects of chronic estradiol treatment on the structure and function
of the thyroid gland in ovarictomized rats as a model simulating menopause.
Findings: Thirty adult female Wistar rats divided into three groups were used in this study; the
first group was sham-operated, while the second and third groups were ovariectomized. The first
and second groups were injected with olive oil while the third group was injected with estradiol
dipropionate daily for three months, after that; hormonal assay for T3, T4, TSH and specimens of
the thyroid were taken and processed to be examined by light and electron microscopy. The
results of this study revealed that serum levels of T3 and T4 decreased in ovariectomized animals
and significantly increased after estradiol treatment, while TSH increased in ovariectomized animals
and decreased with estradiol treatment. Histological and morphometric study in ovariectomized
group revealed marked accumulation of colloid in follicular lumens with decreased epithelial height
in addition to increased connective tissue amount. After estradiol treatment the follicles became
smaller in size, having small amount of colloid with increased epithelial height in addition to
decreased connective tissue content. Ultrastructural study supported these results in addition to
the presence of large amount of intracytoplasmic colloid vesicles after estradiol treatment.
Conclusion: Low estrogen level may lead to mild thyroidal hypofunction while estradiol treatment
may lead to hyperactivity so it should be used very cautiously in the treatment of postmenopausal
symptoms to avoid its undesirable stimulatory effect on the thyroid.
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Background
There is a great wealth of published data on the value of
estrogen therapy in alleviating menopausal symptoms
such as hot flushes and insomnia and in preventing uro-
genital atrophy and osteoporosis [1].
During hormonal therapy both beneficial and undesira-
ble side effects appear due to multiple target organs for
estrogen [2]. Epidemiological studies suggest that the use
of estrogen may contribute to the pathogenesis of thyroid
tumors [3] additionally; thyroid diseases are more com-
mon in women [4].
Although some studies have demonstrated influences of
estrogen on the development, physiology and histology of
the thyroid gland, questions about the effects of estrogen
replacement therapy on the thyroid gland remained unan-
swered [5].
As regard the effect of estradiol on thyroid activity; numer-
ous studies have demonstrated contradictory results either
stimulatory effect through activation of pituitary-thyroid
axis following estradiol treatment [6,7] or no alterations
of TSH although decreased T3 in ovariectomized rats
which became normal after estradiol treatment [8].
In women treated with conjugated estrogen 0.625-2.5
mg/kg/day, there was no change in serum TSH concentra-
tions [9]. In other studies; perimenopausal and postmen-
opausal women had "elevated" serum TSH
concentrations after 1 month [10] or 6 weeks [11] of
estrogen therapy.
Having in mind discrepancies in literature, this study
aimed to examine the effects of chronic estradiol treat-
ment on structure and function of thyroid gland in ovaric-
tomized rats as an animal model for menopause.
Methods
Animals
Thirty adult female Wistar albino rats of 200 - 220 g body
weight were used in this study; they were obtained and
housed in the animal house of Kasr-El-Aini Faculty of
Medicine, Cairo University, Egypt. The animals received a
standard diet for rodents and allowed free access to water.
The animals were treated humanely and care was taken to
ease suffering.
Surgical procedure
The animals were divided randomly into three groups of
ten animals each. The first group (Group I) was sham-
operated. The other two groups were ovariectomized. All
animals were anaesthetized with intraperitoneal injection
of Phenobarbital sodium (15 mg/kg body weight). The
lower abdomen of the rats was shaved and incised. Fallo-
pian tubes and ovaries were identified. Absorbable catgut
sutures were used to tie the Fallopian tubes below the ova-
ries. Then, the ovaries were removed. Sham-operated
group underwent a similar surgical incision exposing the
ovaries and replacing them in the same position [12].
Treatment protocol
One month after surgical procedures, rats of the first and
second groups were injected intra peritoneal (i.p) with
sterile olive oil once daily for three months. The third
group was injected (i.p) with 0.625 mg/kg bw. estradiol
dipropionate (EDP) (Sigma Chemical Co.), dissolved in
sterile olive oil once daily for the same duration. This dose
is equivalent to a commonly used dose for estrogen
replacement in the clinical practice in postmenopausal
women and used in previous experimental designs [13].
This study has been approved by the ethics committee on
animal research in the animal house of Kasr-El-Aini Fac-
ulty of Medicine, Cairo University, Egypt following inter-




At the end of experimental period, blood samples were
collected from the tail vein of all animals and centrifuged
at 3000 rpm for ten minutes. Sera were separated and
stored at -20°C until hormonal assay.
Total T3 and T4 levels were measured by radioimmu-
noassay (RIA) using commercial kits (Coat-A-Coat), while
Serum TSH was measured by RIA using a specific rat TSH
kit (supplied by Diagnostic Products Corporation DPC,
Los Angeles, USA). Radioactivity was determined by the
gamma-counter [15].
The data were presented as mean ± SD.
Histological study
Twenty four hours after the last injection, all animals were
anaesthetized with Phenobarbital sodium, and after int-
racardiac perfusion with the fixative solution (2% gluter-
aldehyde in phosphate buffer), the thyroid glands were
removed together with a portion of the adjoining trachea.
One lobe of the thyroid gland of the animals were dis-
sected, cut into small cubes (about 1 mm3) and immedi-
ately fixed in 2% gluteraldehyde. for electron microscopic
study:
Light microscopic study
The remaining lobes of the thyroids were fixed in Bouin's
solution and processed for paraffin sections that were
stained with Hx&E, Periodic Acid Schiff (PAS) and Mas-
son's trichrome stains.BMC Research Notes 2009, 2:173 http://www.biomedcentral.com/1756-0500/2/173
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Morphometry
The data were obtained by using "Leica Qwin 500" image
analyzer computer system (England). The measurements
were done using an objective lens of magnification 40,
examining the central regions of the glands. (peripheral
and isthmic follicles were excluded).
Epithelial height and follicular area were measured in sec-
tions stained with Hx&E. colloidal area percent was
assessed in PAS stained sections and connective tissue area
percent in sections stained with Masson's trichrome stain.
For each parameter, ten readings per animal in each group
were done.
Electron microscopic study
Small fragments from the thyroid glands were rinsed in
phosphate buffer (PH 7.4) fixed in 2% gluteraldehyde,
postfixed in 1% osmium tetroxide and dehydrated. After
embedding in ultrathin sections were cut and stained with
lead citrate and uranyl acetate. The grids were examined
and photographed with electron microscope.
Statistical analysis
The data obtained from hormonal assay and morphome-
try were presented as mean ± SD. Data analysis was per-
formed using "SPSS" Statistical Analysis System Software.
The obtained data were analyzed through the use of the
analysis of variance (ANOVA). Comparison among each
two groups was performed using the t-test. The significant
differences were defined as P < 0.05.
Results
Hormonal assay
Animals underwent ovariectomy demonstrated decreased
serum levels of T3 and T4 with increase of TSH levels
when compared to the control and estradiol treated
groups. Animals treated with estradiol demonstrated
highly statistically significant increased levels of T3, T4
and decrease in TSH levels when compared to both con-
trol and ovariectomized groups (table 1).
Light microscopic results
In the sham-operated group, the thyroid gland was found
to be composed of thyroid follicles which appeared gen-
erally oval or rounded lined with a single layer of cells.
The central follicles appeared smaller in size than periph-
eral ones. The central follicles were lined with cuboidal
cells with rounded nuclei, while the epithelial lining of
the peripheral follicles was formed of flattened or low
cuboidal cells. The amount of colloid substance varied
from one follicular lumen to another. It showed different
staining affinity with PAS. Some follicles contained con-
spicuous peripheral vacuoles. The connective tissue cap-
sule was thin and the connective tissue septa were hardly
identified dividing the gland into numerous small ill-
defined lobules (fig. 1a-d).
In the ovariectomized rats, preserved secretory activity of
the thyroid gland was noticed, it was mainly characterized
by central follicles of a flattened, cuboidal or low pris-
matic epithelium surrounding the colloid. Occasionally,
enlarged distended follicles with very flat epithelium were
noticed. The peripheral follicles were large and lined with
flattened epithelium. The colloid appeared filling up the
entire lumen in most of the follicles with no or little
peripheral vacuolization. The connective tissue around
the follicles was more prominent than in sham-operated
group (fig. 2a-d).
The thyroid gland of estradiol treated group demonstrated
very small follicles in the central region with high colum-
nar or pyramidal epithelial lining surrounding narrow
lumen. There were areas of disorganized follicles with
complete obstruction of their lumina. The peripheral fol-
licles were larger. The colloid was faintly stained and dem-
onstrated extensive vacuolization. Connective tissue was
minimal between the follicles (fig. 3a-d).
Morphometric analysis of light microscopic results
In ovariectomized group, epithelial height was signifi-
cantly decreased while the follicular area, colloidal area
percent and connective tissue content were significantly
increased when compared to sham-operated group.
In estradiol treated group, there was marked increase in
epithelial height and decreased follicular area and colloi-
dal area percent when compared to the other two groups.
Connective tissue content was more or less similar to the
Table 1: changes in the mean serum levels of thyroid hormones T3, T4 and TSH in the different groups
Mean ± SD Group 1 (sham operated) Group 2 (ovariectomized) Group 3 (estradiol treated)
T3 ng/dL 54.001 ± 2.29 52.754 ± 2.14 65.007 ± 4.79*#
T4 ng/dL 66.021 ± 1.32 63.592 ± 1.46 80.615 ± 3.61*#
TSH microU/dL 33.96 ± 1.86 36.161 ± 1.46 24.587 ± 3.2*#
Marked differences * are significant at p < .05 compared to Group 1 (sham operated)
Marked differences # are significant at p < .05 compared to Group 2 (ovariectomized)BMC Research Notes 2009, 2:173 http://www.biomedcentral.com/1756-0500/2/173
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sham-operated group. These results were summarized in
(table 2).
Electron microscopic results
Electron microscopic study of the thyroid follicles in con-
trol sham operated rats showed rounded follicles formed
of cuboidal cells with rounded nuclei. The follicles are
bounded with a basement membrane and surrounded
with capillaries. The cells are rich in rough endoplasmic
reticulum and mitochondria in addition to a prominent
Golgi apparatus and intracytoplasmic colloid vesicles. The
apex of the cells adjacent to the follicular lumen showed
apical cytoplasmic vacuolization with the presence of
many lysosomes (fig. 4a).
Electron microscopic study of the thyroid follicles in ova-
riectomized rats showed thyroid follicles with cuboidal
cells with rounded nuclei. Intracytoplasmic colloid vesi-
cles were more prominent with well developed Golgi
apparatus. In addition to that the apical cytoplasmic vac-
uolization and lysosomes could be demonstrated (fig 4b).
Electron microscopic study of the thyroid follicles in ova-
riectomized rats treated with estradiol showed increased
activity of thyroid follicular columnar cells with oval
nuclei and intracytoplasmic colloid vesicles which were
much more prominent with clear apical cytoplasmic vac-
uolization (fig. 4c).
Discussion
The end of the reproductive lifespan, in females of many
species, is associated with hypoestrogenic state that lead
to other physiological changes with increased risk of oste-
oporosis and cardiovascular diseases. Estrogen replace-
ment therapy was accepted for prevention and treatment
of human menopausal problems [16]. Unfortunately,
recent evidence has connected hormonal treatment with
undesirable side effects especially as a carcinogenic stimu-
lator of cell proliferation and inducing genetic damage
[17].
The main goal of the present study was to elucidate the
effects of chronic estradiol treatment on thyroid gland
structure and function in ovariectomized rat model, in
doses comparable with those used in human therapy.
In the present study, ovariectomized rats demonstrated a
decrease in the levels of T3 and T4 with an increase in the
level of TSH when compared to animals with intact ova-
ries. A recent study by De Araujo et al. [7], demonstrated
light microscopic pictures of thyroid gland from sham oper- ated rats Figure 1
light microscopic pictures of thyroid gland from 
sham operated rats. (a) Large peripheral thyroid follicles 
(thick arrows) under the capsule (caps) lined with flattened 
and cuboidal epithelial lining (thin arrows) filled with colloid 
(C). The central follicles appear smaller in size (Hx&E × 200). 
(b) Higher magnification of the central zone from the previ-
ous section. The epithelial lining of the follicles is cuboidal 
(thin arrows) with rounded central or basal nuclei. The folli-
cles are variable in size. The colloid contains peripheral vacu-
olization (arrow heads) (Hx&E × 400). (c) The central zone 
of thyroid of sham-operated rats showing variable amount of 
colloid filling the lumina of the follicles (C) (PAS × 400). (d) 
There is minimal amount of connective tissue in between the 
follicles (thin arrows) (Masson trichrome × 400).
light microscopic pictures of thyroid gland of group II (ovaric- tomized rat) Figure 2
light microscopic pictures of thyroid gland of group II 
(ovarictomized rat). (a) large peripheral thyroid follicles 
(thick arrows) beneath the capsule (caps). The central ones 
are variable in size with cuboidal and flattened epithelial lining 
(thin arrows) (Hx&E × 200). (b) higher magnification of the 
central zone from the previous section showing enlarged fol-
licles (thick arrows) with flat epithelial lining and flattened 
nuclei of many cells (thin arrows). The colloid demonstrates 
minimal vacuolization (arrow heads) (Hx&E × 400). (c) folli-
cles distended with large amount of colloid (C) (PAS × 400). 
(d) increased connective tissue in between the thyroid folli-
cles (thin arrows) (Masson trichrome × 400).BMC Research Notes 2009, 2:173 http://www.biomedcentral.com/1756-0500/2/173
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similar findings in ovariectomized rats. Also high levels of
TSH were recorded in postmenopausal women in several
studies [2,18]. While Sosic-Jurjevic et al. [19] reported
increased levels of T3 and T4 this difference may be due to
a shorter duration of estrogen administration.
In the present study, serum thyroid hormone levels seem
to reflect the histological and morphometric changes in
thyroid glands. In ovariectomized rats; the follicles were
lined with low prismatic, cuboidal or flattened epithelium
with significant decrease in epithelial height. The follicu-
lar area was increased as well as colloidal area percent.
These findings indicated hypoactivity of the thyroid gland
[20].
Estrogen has antifibrotic effects through the inhibition of
key profibrotic factors, and through attenuation of fibrob-
last differentiation [21]. So the increased connective tissue
content shown in this study in ovariectomized rats could
be due to decreased estrogen antifibrotic effects as a result
of estrogen withdrawal.
In our study electron microscopic examination of the thy-
roid gland from ovariectomized rats showed the cuboidal
follicular cells with increased amount of intracytoplasmic
colloid vesicles. While with estradiol treatment in ovariec-
tomized rats, the follicular cells appeared columnar with
oval nuclei with much more prominent intracytoplasmic
colloid vesicles and clear apical vacuolization.
Zayed et al. [22] also reported decreased follicular colloid
with increased intracytoplasmic colloid vesicles due to
decreased activity of thyroid gland after ovariectomy with
increased intracytoplasmic vesicles stored later as colloid
in the follicular lumen which became wider.
Meanwhile, some reports have shown that the effects of
estrogens on the thyroid gland may be indirect through
the pituitary-thyroid axis [18] or as a consequence of
increased serum levels of thyroxin binding globulin and
the associated changes in thyroid function [23].
Taken together, the present results demonstrate that the
thyroid glands of rats remain susceptible to the influence
of ovariectomy and estrogen. The growth stimulatory
effect of estrogen on benign and malignant human thy-
roid cells support the epidemiological data showing
higher prevalence of thyroid carcinomas in females [24].
Although the extrapolation of these results to human
should be interpreted with caution, it is highly conceiva-
ble that monitoring of thyroid function may be important
for patients who are under or going to be under estrogen
therapy.
light microscopic pictures of thyroid gland of group III  (ovarictomized rat treated with estradiol) Figure 3
light microscopic pictures of thyroid gland of group 
III (ovarictomized rat treated with estradiol). (a) The 
peripheral follicles (thick arrows) under the capsule (caps) 
are relatively larger than the central follicles (Hx&E × 200). 
(b) Higher magnification of the central zone showing very 
small follicles. Some follicles have no apparent lumina (thick 
arrows), while others contain absent or highly vacuolated 
colloid material (arrow heads) (Hx&E × 400). (c) There is lit-
tle amount of the colloid in some follicles (C) while others 
demonstrate absent colloid (thin arrows) (PAS × 400). (d) 
There is minimal connective tissue (thin arrows) surrounding 
the thyroid follicles (Masson trichrome × 400).
Table 2: the statistical analysis of the morphometric data obtained by the image analysis
Mean ± SD Group 1 (sham operated) Group 2 (ovariectomized) Group 3 (estradiol treated)
Epithelial height 9.05 ± 0.83 7.577 ± 0.9* 11.306 ± 0.83*#
Follicular area 3104.15 ± 216 4485.01 ± 577* 1841.78 ± 146*#
Colloidal area % 18.158 ± 1.34 23.958 ± 1.53* 8.16 ± 0.71*#
Connective tissue area % 1.36544 ± 1.24# 4.72668 ± 0.43* 1.3625 ± 0.19#
Marked differences * are significant at p < .05 compared to Group 1 (sham operated)
Marked differences # are significant at p < .05 compared to Group 2 (ovariectomized)BMC Research Notes 2009, 2:173 http://www.biomedcentral.com/1756-0500/2/173
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Conclusion
Decreased amount of estrogen may lead to thyroid hypo-
function while estradiol treatment may lead to hyperactiv-
ity so it should be used very cautiously in the treatment of
postmenopausal symptoms to avoid its undesirable stim-
ulatory effect on the thyroid.
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